Disease details

Clinical trials : 3,340 / Drugs : 2,163 - (DrugBank : 383) / Drug target genes : 241 - Drug target pathways : 238

2 trials found

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT02121444 (ClinicalTrials.gov)	June 23, 2014	22/4/2014	BAY86-5046 (Betaseron), Non Interventional Studies	BETAEVAL - The New BETACONNECT® Auto-injector: Adherence and EVALuation of MS Patients Treated With Betaferon®	Multiple Sclerosis	Drug: Interferon beta -1b (Betaferon, BAY 86-5046);Device: BETACONNECT auto-injector.	Bayer	NULL	Completed	18 Years	N/A	All	151	N/A	Germany
2	NCT01766063 (ClinicalTrials.gov)	December 6, 2012	7/12/2012	Investigating the Relationship Between Sleep, Quality of Life,Other Disorders and Therapies in MS Patients on Betaferon	BETASLEEP - SLEEP Quality and Functional Health Status, Fatigue, Comorbidities and Therapeutic Algorithms Among BETAferon® Treated MS Patients	Multiple Sclerosis	Drug: Interferon beta -1b (Betaferon, BAY 86-5046)	Bayer	NULL	Completed	18 Years	N/A	All	138		Germany